Marino Lab

Advancing Drug Discovery for Alzheimer’s Disease

About Marino Lab

Our Goals

We strive to understand underlying biophysical, biomolecular, and physiological mechanisms involved in the prevention and progression of neurodegenerative disorders, with a primary emphasis on Alzheimer’s disease (AD).

Our laboratory aims to translate these mechanistic insights into the development of novel, disease-modifying therapies for AD and related neurodegenerative conditions.

Key areas of investigation

Mechanisms of Resilience: Marino’s lab investigates the biological mechanisms that confer resilience and/or resistance against the neuropathology of Alzheimer’s disease.

Drug Target Discovery and Therapeutic development: Our research proposes novel druggable targets relevant to Alzheimer’s disease, particularly those that mimic natural resilience mechanisms.

Translational Approaches: We aim to move discoveries from basic science into potential clinical applications, focusing on disease-modifying therapies using biophysical, biomolecular and in vivo approaches.

image of mouse brain, section neurons and cell transfection

Publications

Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators

O'Hare, M., Amarnani, D., Whitmore, H. A. B., An, M., Marino, C., Ramos, L., Delgado-Tirado, S., Hu, X., Chmielewska, N., Chandrahas, A., Fitzek, A., Heinrich, F., Steurer, S., Ondruschka, B., Glatzel, M., Krasemann, S., Sepulveda-Falla, D., Lagares, D., Pedron, J. & Bushweller, J. H. & 3 others, Liu, P., Arboleda-Velasquez, J. F. & Kim, L. A., Jul 2021, In: American Journal of Pathology. 191, 7, p. 1193-1208 16 p.

Research output: Contribution to journal › Article › peer-review

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

Arboleda-Velasquez, J. F., Lopera, F., O’Hare, M., Delgado-Tirado, S., Marino, C., Chmielewska, N., Saez-Torres, K. L., Amarnani, D., Schultz, A. P., Sperling, R. A., Leyton-Cifuentes, D., Chen, K., Baena, A., Aguillon, D., Rios-Romenets, S., Giraldo, M., Guzmán-Vélez, E., Norton, D. J., Pardilla-Delgado, E. & Artola, A. & 24 others, Sanchez, J. S., Acosta-Uribe, J., Lalli, M., Kosik, K. S., Huentelman, M. J., Zetterberg, H., Blennow, K., Reiman, R. A., Luo, J., Chen, Y., Thiyyagura, P., Su, Y., Jun, G. R., Naymik, M., Gai, X., Bootwalla, M., Ji, J., Shen, L., Miller, J. B., Kim, L. A., Tariot, P. N., Johnson, K. A., Reiman, E. M. & Quiroz, Y. T., Nov 1 2019, In: Nature Medicine. 25, 11, p. 1680-1683 4 p.

Research output: Contribution to journal › Article › peer-review

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

Arboleda-Velasquez, J. F., Lopera, F., O’Hare, M., Delgado-Tirado, S., Marino, C., Chmielewska, N., Saez-Torres, K. L., Amarnani, D., Schultz, A. P., Sperling, R. A., Leyton-Cifuentes, D., Chen, K., Baena, A., Aguillon, D., Rios-Romenets, S., Giraldo, M., Guzmán-Vélez, E., Norton, D. J., Pardilla-Delgado, E. & Artola, A. & 24 others, Sanchez, J. S., Acosta-Uribe, J., Lalli, M., Kosik, K. S., Huentelman, M. J., Zetterberg, H., Blennow, K., Reiman, R. A., Luo, J., Chen, Y., Thiyyagura, P., Su, Y., Jun, G. R., Naymik, M., Gai, X., Bootwalla, M., Ji, J., Shen, L., Miller, J. B., Kim, L. A., Tariot, P. N., Johnson, K. A., Reiman, E. M. & Quiroz, Y. T., Nov 1 2019, In: Nature Medicine. 25, 11, p. 1680-1683 4 p.

Research output: Contribution to journal › Article › peer-review

Complete list of publications 

Contact us

If you are interested in joining our team, or if you want to know more about our work, feel free to contact us.

Contact us